RESTRICTIVE CARDIOMYOPATHY

This adverse event was reported 303 times

RESTRICTIVE CARDIOMYOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLOROQUINE PHOSPHATE 10 0.0152
1 PENTAMIDINE ISETHIONATE 8 0.0064
2 PROTAMINE SULFATE 9 0.0049
3 DAUNORUBICIN HYDROCHLORIDE 7 0.0042
4 CEFOTAXIME INJECTION 9 0.0021
5 MITOXANTRONE HYDROCHLORIDE 11 0.0017
6 ALDESLEUKIN 2 0.0016
7 DOBUTAMINE HYDROCHLORIDE 2 0.0015
8 FLUCYTOSINE 2 0.0014
9 PHYTONADIONE 11 0.0013
See all drugs enriched for association with RESTRICTIVE CARDIOMYOPATHY

RESTRICTIVE CARDIOMYOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lymphocyte Growth Factor [EPC] 2 0.0016
1 Nucleoside Analog Antifungal [EPC] 2 0.0014
2 Vitamin K [EPC] 11 0.0013
3 Pyruvate Kinase Activator [EPC] 1 0.0008
4 Anticholinergic [EPC] 11 0.0007
5 CD38-directed Cytolytic Antibody [EPC] 3 0.0005
6 Anthelmintic [EPC] 1 0.0003
7 Polyene Antifungal [EPC] 13 0.0003
8 Penem Antibacterial [EPC] 11 0.0003
9 Cholinergic Muscarinic Antagonist [EPC] 12 0.0003
See all drug classes enriched for association with RESTRICTIVE CARDIOMYOPATHY